BSE filing, NSE: SUDARSHAN. Summary written from the filing by ALFA Finder's alert engine.
Sudarshan Pharma Industries Ltd: key numbers
- Share price
- ₹38.00
- Market cap
- ₹914.5 Cr
- Revenue (annual)
- ₹703.1 Cr
- Net profit (annual)
- ₹23.30 Cr
- P/E (TTM)
- 39.2×Sector 34.5×
- Promoter holding
- 57.81%-1.12% QoQ
- FII holding
- 21.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sudarshan Pharma Industries Ltd
All →Sudarshan Pharma Industries Board Meeting Date
Sudarshan Pharma's board meets 29 October 2026 to consider Q2 results and a fund-raising proposal. Trading window remains closed until 48 hours after results.
Sudarshan Pharma Industries Other Announcement
Sudarshan Pharma Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Sudarshan Pharma Industries Merger & Restructuring
Sudarshan Pharma terminated its proposal to acquire 9.50% of Med Therapy Biotechnology Inc. The promoters' parallel 1.50% each acquisition plan also stands terminated.
Sudarshan Pharma Industries Merger & Restructuring Worth ₹1.4 Cr
Sudarshan Pharma Industries completed the sale of its 51% stake in subsidiary Ishwari Healthcare Private Limited for ₹1.40 Crore. The entity ceases to be a subsidiary.
- Value
- ₹1.40 Cr
Sudarshan Pharma Industries Annual General Meeting
Sudarshan Pharma Industries Ltd held its 18th Annual General Meeting on September 22, 2026. The meeting covered the adoption of financial statements and director re-appointment.
Sudarshan Pharma Industries Acquisition
Sudarshan Pharma stated its proposed 9.50% stake acquisition of Med Therapy Biotechnology Inc. remains under due diligence. Promoter acquisitions of 1.50% each are also pending.
Other sme to main board migration announcements
All →Arham Technologies SME to Main Board Migration
Arham Technologies received NSE approval to migrate from SME Emerge to the Main Board, effective October 30, 2026. Trading under symbol ARHAM starts on the Main Board.
Essen Speciality Films SME to Main Board Migration
Essen Speciality Films received NSE in-principle approval for migrating from the Emerge platform to the NSE Main Board. Completion of migration formalities is still pending.
Karnika Industries SME to Main Board Migration
Karnika Industries seeks shareholder approval via postal ballot to migrate from NSE Emerge to NSE and BSE Main Boards. Voting runs October 29 to November 27, 2026.
Bondada Engineering SME to Main Board Migration
Bondada Engineering received NSE listing approval for migration from BSE SME to NSE Main Board. The milestone broadens investor reach and supports long-term growth.
Felix Industries SME to Main Board Migration
Felix Industries filed an addendum to its scrutinizer's report confirming separate voting for the SME-to-Main Board migration resolution. The Regulation 277 voting threshold was met.
Viaz Tyres SME to Main Board Migration
Viaz Tyres seeks postal ballot approval for NSE Emerge-to-Main Board migration, ESOP 2026 and an independent director. E-voting runs 27 October to 25 November 2026.